ENLARGED FOLLICLES IN WOMEN USING ORAL-CONTRACEPTIVES

被引:21
|
作者
BROOME, M
CLAYTON, J
FOTHERBY, K
机构
[1] ROYAL POSTGRAD MED SCH,LONDON W12 0NN,ENGLAND
[2] FAMILY PLANNING CLIN,READING RG1 5LB,BERKS,ENGLAND
[3] ROYAL BERKSHIRE HOSP,READING,BERKS,ENGLAND
关键词
ORAL CONTRACEPTIVES; PROGESTOGEN ONLY PILL; ULTRASOUND; OVARIAN CYSTS; FOLLICULAR ENLARGEMENT;
D O I
10.1016/0010-7824(95)00127-V
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Ultrasound examination of the ovaries was performed in the first and/or second half of three consecutive cycles in 3 groups of women; Group T who had been using a levonorgestrel triphasic oral contraceptive for at least 6 months, Group P who had been using a progestogen-only pill for at least 6 months, and Group C, a control group. Any follicles greater than 10 mm in diameter and any cysts were measured. Fifty-three scans were performed in Group T, 45 in Group P and 31 in Group C. Only 4 follicles were detected in 17 women in Group T compared to 10 follicles in 15 women in Group P and 7 follicles in the 10 women in Group C; all follicles were 25 mm or less in diameter except for 3 follicles in 2 women. The differences between the groups were not statistically significant. Four enlarged follicles were detected in 3 women during 53 scans in Group T, 15 in 8 women (45 scans) in Group P and only 1 in 31 scans in Group C. Based upon the proportions of scans with enlarged follicles, the difference between Groups T and P was statistically significant, indicating that the incidence of enlarged follicles was lower in women using a combined oral contraceptive than in those using a progestogen-only pill. Furthermore, the study shows that any enlarged follicles which occurred were transient.
引用
收藏
页码:13 / 16
页数:4
相关论文
共 50 条
  • [1] INTERACTIONS WITH ORAL-CONTRACEPTIVES
    FOTHERBY, K
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (06) : 2153 - 2159
  • [2] COMPLIANCE AND ORAL-CONTRACEPTIVES - A REVIEW
    ROSENBERG, MJ
    BURNHILL, MS
    WAUGH, MS
    GRIMES, DA
    HILLARD, PJA
    CONTRACEPTION, 1995, 52 (03) : 137 - 141
  • [3] AN EPIDEMIOLOGIC SURVEY OF CARDIOVASCULAR-DISEASE IN WOMEN TAKING ORAL-CONTRACEPTIVES
    THOROGOOD, M
    VESSEY, MP
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (01) : 274 - 281
  • [4] PULMONARY EMBOLUS IN AN ADOLESCENT ON ORAL-CONTRACEPTIVES
    KEY, JD
    HAMMILL, WW
    EVERETT, L
    JOURNAL OF ADOLESCENT HEALTH, 1992, 13 (08) : 713 - 715
  • [5] ORAL-CONTRACEPTIVES, FIBRINOGEN AND CARDIOVASCULAR RISK
    ERNST, E
    ATHEROSCLEROSIS, 1992, 93 (1-2) : 1 - 5
  • [6] ORAL-CONTRACEPTIVES AND THE RISK OF ENDOMETRIAL CANCER
    LEVI, F
    LAVECCHIA, C
    GULIE, C
    NEGRI, E
    MONNIER, V
    FRANCESCHI, S
    DELALOYE, JF
    DEGRANDI, P
    CANCER CAUSES & CONTROL, 1991, 2 (02) : 99 - 103
  • [7] ORAL-CONTRACEPTIVES AND MYOCARDIAL-INFARCTION
    THORNEYCROFT, IH
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (04) : 1393 - 1397
  • [8] TYROSINE METABOLISM IN USERS OF ORAL-CONTRACEPTIVES
    MOLLER, SE
    MAACHMOLLER, B
    OLESEN, M
    MADSEN, B
    MADSEN, P
    FJALLAND, B
    LIFE SCIENCES, 1995, 56 (09) : 687 - 695
  • [9] THE EFFECT OF TETRACYCLINE ON LEVELS OF ORAL-CONTRACEPTIVES
    MURPHY, AA
    ZACUR, HA
    CHARACHE, P
    BURKMAN, RT
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1991, 164 (01) : 28 - 33
  • [10] BENEFITS AND RISKS OF COMBINED ORAL-CONTRACEPTIVES
    VESSEY, MP
    METHODS OF INFORMATION IN MEDICINE, 1993, 32 (03) : 222 - 224